GA4GH GEM Japan (GEnome Medicine Alliance Japan)
The Global Alliance for Genomics and Health (GA4GH ) is an international organization aiming to advance medical care and medicine through responsible sharing of genomic and health-related data.
The GEM Japan (GEnome Medicine Alliance Japan) has been designated as a GA4GH Driver Project , pursuing integration of the results of AMED projects to realize genomic medicine in Japan.
Michael Baudis, Swiss Personalized Health Network, visited AMED to have an in-person meeting with Japanese Data Scientists
AMED held the GEM Japan Workshop titled Global Career Advancement of Genome and Health Data Scientists
News Release & Research Results
Discovering genetic variations for genomic studies in populations across Asia: Whole-genome sequencing of over 200 population groups in 64 countries
Commencement of the Biobank cross-search System, where 650,000 samples and/or 200,000 data owned by seven Biobank institutes in Japan can be accessed at once
The acquired mechanisms underlying the loss of the Y chromosome ―Phenomena associated with cellular aging and tumorigenesis based on DNA data―
Elucidation of genetic features associated with human height in a Japanese population: An approach to uncovering the mysteries of genetic factors associated with human height in a Japanese population utilizing the analysis of 190,000 individuals
Study develops a method to accurately predict prognosis and treatment response in patients with heart failure ―Elucidates the clinical importance of DNA damage in myocardium in heart failure―
Tohoku Medical Megabank Organization develops Japonica Array® NEO―Makes it possible to apply genome sequencing to a wider range of people―
Significant expansion of data listed in jMorp serving as a public database of genome-omics analysis information with the sample number increased to 15,000 and 4,700 respectively for metabolome analysis data (including longitudinal data) and whole-genome analysis
Study identifies the pathogenic mechanism of porokeratosis ― Reveals that 1 out of 400 Japanese has a congenital predisposition to develop the disease ―
Commencement of add-on cohort program for a study investigating how genetic polymorphism, as well as brain imaging and cognitive function, are associated with olfaction
International approval of a novel blood type “KANNO”: Achievement of the National Center for Global Health and Medicine as the first Japanese institution to be recognized
Past News Release & Research Results
The GEM Japan project, which has covered Program for an Integrated Database of Clinical and Genomic Information, Platform Program for Promotion of Genome Medicine, BioBank Japan Project for Genomic and Clinical Research, Tohoku Medical Megabank Project in Japan, plans to share the allele frequencies as well as disease variations of Japanese population, and has held GEM Japan workshops in order to localize the GA4GH tools into non-English speaking countries.
- TogoVar (Integrated database of Japanese genomic variation) : A database that has collected and organized genome sequence differences between individuals (variants), which has been developed as a joint research project of National Bioscience Database Center (NBDC), JST, and Database Center for Life Science (DBCLS), ROIS.
- MGeND(Medical Genomics Japan Variant Database) : A database aiming to provide the integrated information of genomic variations and clinical characteristics, which has been developed by the AMED program for an Integrated Database of Clinical and Genomic Information.
- BBJ(BioBank Japan) : One of the three major biobanks in Japan managed by the AMED BioBank Japan Project for Genomic and Clinical Research.It has collected DNA, serum and clinical information from more than 270,000 patients nationwide, and thus is regarded as one of the largest disease biobanks in the world.
- TMM (Tohoku Medical Megabank Project) : The project conducts a long-term health study of a total of 150,000 residents living in communities which suffered major damage from the Great East Japan Earthquake and reports the findings to the respective residents with their personal information. It also establishes a system of dispatching physicians on a rotation basis to health care providers in the region.
SUEMATSU Makoto, M.D., Ph.D.
NAKAGAWA Hidewaki, M.D., Ph.D.
AMED Program Officer
Team Leader, Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences
KOSAKI Kenjiro, M.D., Ph.D.
AMED Program Officer
Professor and Director, Center for Medical Genetics, Keio University School of Medicine
Data and its sharing database
- Open Data：NBDC Human Database MGeND
- Controlled-Access Data：NBDC Human Database
- Group Sharing Data：AGD（Japanese Only）
Overviews of the data produced by R&D projects which are in scope of the policy are here (Japanese only).
Japan Agency for Medical Research and Development (AMED)
GEM Japan Contact Office
Last updated 2020.1.22